Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Maxwell Stefan
Introduction
Maxwell Stefan is a prominent inventor based in Pleasanton, CA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of targeted therapies. With a total of 4 patents to his name, his work focuses on advancing medical treatments through innovative antibody technologies.
Latest Patents
Maxwell's latest patents include groundbreaking research on lung-targeting single-domain antibodies and purification methods. These single-domain antibodies (sdABs) are designed to target human or mammalian lung tissue. The constructs and methods described in this patent include techniques for binding and transporting other sdABs or cargo with beneficial functionalities. Additionally, it outlines methods for treating, diagnosing, or prophylactically addressing diseases, conditions, or malignancies. Another significant patent involves brain-targeting single-domain antibodies that can pass the blood-brain barrier in humans or mammals. This patent details methods for binding to brain cells and transporting biochemical or pharmaceutical species, which can be crucial for treating various conditions.
Career Highlights
Maxwell Stefan is currently employed at National Technology & Engineering Solutions of Sandia, LLC. His role at this esteemed organization allows him to leverage his expertise in developing innovative solutions for complex biomedical challenges. His work has the potential to significantly impact the field of medicine and improve patient outcomes.
Collaborations
Maxwell collaborates with talented individuals such as Brooke Nicole Harmon and Yooli Kim Light. These partnerships enhance the innovative capacity of his projects and contribute to the advancement of their shared goals in biomedical research.
Conclusion
Maxwell Stefan's contributions to the field of biomedical engineering through his patents and collaborative efforts highlight his commitment to innovation. His work in developing targeted therapies has the potential to transform medical treatments and improve the quality of life for many patients.